CR7761A - CONTROLLED RELEASE PREPARATION - Google Patents

CONTROLLED RELEASE PREPARATION

Info

Publication number
CR7761A
CR7761A CR7761A CR7761A CR7761A CR 7761 A CR7761 A CR 7761A CR 7761 A CR7761 A CR 7761A CR 7761 A CR7761 A CR 7761A CR 7761 A CR7761 A CR 7761A
Authority
CR
Costa Rica
Prior art keywords
active ingredient
controlled
controlled release
granule
release preparation
Prior art date
Application number
CR7761A
Other languages
Spanish (es)
Inventor
Nagahara Naoki
Akiyama Yohko
Kurasawa Takashi
Bando Hiroto
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR7761A publication Critical patent/CR7761A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se provee una preparacion de liberacion controlada en la cual la liberacion del ingrediente activo esta controlada, la cua libera un ingrediente activo durante un periodo prolongado de tiempo permaneciendo o migrando lentamente por el tracto gastrointestinal, mediante el encapsulamiento de una tableta, granulo o granulo fino en los cuales la liberacion del ingrediente activo esta controlada y un prolimero formador de geles. Dicha tableta, granulo o granulo fino presenta una capa de recubrimiento de liberacion controlada formada sobre una particula central que tiene un ingrediente activo.A controlled release preparation is provided in which the release of the active ingredient is controlled, which releases an active ingredient for a prolonged period of time by remaining or migrating slowly through the gastrointestinal tract, by encapsulating a tablet, granule or fine granule. in which the release of the active ingredient is controlled and a prolific gel former. Said tablet, granule or fine granule has a controlled release coating layer formed on a central particle having an active ingredient.

CR7761A 2002-10-16 2005-03-18 CONTROLLED RELEASE PREPARATION CR7761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002301876 2002-10-16

Publications (1)

Publication Number Publication Date
CR7761A true CR7761A (en) 2005-06-09

Family

ID=35719193

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7761A CR7761A (en) 2002-10-16 2005-03-18 CONTROLLED RELEASE PREPARATION

Country Status (4)

Country Link
CN (1) CN1713897B (en)
AR (1) AR103296A2 (en)
CR (1) CR7761A (en)
ZA (1) ZA200502318B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049160A1 (en) * 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Methods of treating gastrointestinal disorders independent of the intake of food
RU2593939C2 (en) * 2008-11-13 2016-08-10 Ногра Фарма Лимитед Antisense compositions and methods for production and use thereof
CA2781286A1 (en) * 2009-11-20 2011-05-26 Handa Pharmaceuticals, Llc Oral formulation for dexlansoprazole
PE20170306A1 (en) * 2010-06-16 2017-05-06 Takeda Pharmaceuticals Usa Inc NEW MODIFIED RELEASE DOSAGE FORMS OF A XANTHINE OXIDOR REDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS
CN116440094B (en) * 2022-01-06 2026-04-17 山东新时代药业有限公司 A lansoprazole sustained-release tablet and its preparation method

Also Published As

Publication number Publication date
CN1713897A (en) 2005-12-28
ZA200502318B (en) 2006-11-29
AR103296A2 (en) 2017-05-03
CN1713897B (en) 2012-07-04

Similar Documents

Publication Publication Date Title
CR10284A (en) PREPARATION OF CONTROLLED RELEASE. (DIVISIONAL EXP. 7761)
DK1578406T3 (en) Modified Release Pharmaceutical Composition
JP2005501039A (en) Drug controlled release system with variable release rate
CY1112582T1 (en) Interdermal Fentanyl Administration
DE60335557D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINED AN OPIOIDANAL GETIC
DOP2001000229A (en) HYDROGEL ACTIVATED DRUG DOSAGE FORM
ES2166769T3 (en) COMPRESSED PHARMACEUTICAL CONTROLLED LIBERATION PRESENTING LENTICULAR FORM.
UY27386A1 (en) DRUG RELEASE DEVICE CONTAINING OSELTAMIVIR AND AN H1 ANTAGONIST
AR061860A1 (en) PHARMACEUTICAL PREPRATION FOR ORAL ADMINISTRATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENT IN THE SMALL INTESTINE AND METHOD FOR MANUFACTURING
TW200735421A (en) LED semiconductor body and use of an LED semiconductor body
ATE428407T1 (en) ORAL MEDICINAL FORM WITH OPENINGS IN THE OUTER CASE
CR7761A (en) CONTROLLED RELEASE PREPARATION
ATE519510T1 (en) ANTITHROMBOGENIC AND ANTIRESTENOTIC VASCULAR MEDICAL DEVICES
AR034493A1 (en) COMBINATION OF ACTIVE PRINCIPLES FOR THE MEDICAL TREATMENT OF TOXICOMANS.
NO20071806L (en) Tablets with site and time controlled gastrointestinal release of active ingredient.
WO2006023644A3 (en) Transdermal drug delivery device with translucent protective film
AR028525A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF LERISETRON
AR039232A1 (en) A PHARMACEUTICAL FORMULATION THAT INCLUDES AT LEAST A SELECTED COMPOSITE OF THE GROUP FORMED BY NON-BARBITURIC HYPNOTICS AND NON-BENZODIACEPINICS, AND MELATONIN
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
WO2004109813A3 (en) Light-emitting diode
CO2023005753A2 (en) Modified Release Soft Gelatin Capsules
CR7648A (en) MICROCAPSULES FOR DELAYED AND CONTROLLED LIBERATION OF PERINDROPIL
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
RU2004128402A (en) MEANS FOR RELEASING HOMOCYSTEIN FROM HIS COMMUNICATION WITH PROTEIN OF BLOOD PLASMA
ITRM20010365A1 (en) CIGARETTE DEVICE FOR THE ADMINISTRATION BY AIR OF MEDICINAL AND NON-MEDICINAL SUBSTANCES.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)